Literature DB >> 23931951

Nonmotor symptoms in Parkinson's disease: expanding the view of Parkinson's disease beyond a pure motor, pure dopaminergic problem.

Victor W Sung1, Anthony P Nicholas.   

Abstract

Nonmotor symptoms (NMS) of Parkinson's disease (PD) are critical to identify and treat because of their impact on quality of life. Despite growing evidence of the importance of NMS on patients' quality of life, gaps remain in their recognition and treatment. The result is a need for increased information and understanding of specific NMS and the clinical approaches for their assessment and management in the context of PD as a whole. This article discusses the NMS of PD, their relationship to the pathologic basis of PD, and how NMS can be best managed. Published by Elsevier Inc.

Entities:  

Keywords:  Dopaminergic; Motor symptoms; Nonmotor symptoms; Parkinson's disease

Mesh:

Substances:

Year:  2013        PMID: 23931951     DOI: 10.1016/j.ncl.2013.04.013

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  20 in total

1.  Association of TLR4 gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population.

Authors:  Jing Zhao; Xun Han; Li Xue; Konghua Zhu; Hongxin Liu; Anmu Xie
Journal:  Neurol Sci       Date:  2015-04-25       Impact factor: 3.307

Review 2.  Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders.

Authors:  Shang-Yi A Tsai; Michael J Pokrass; Neal R Klauer; Nicole E De Credico; Tsung-Ping Su
Journal:  Expert Opin Ther Targets       Date:  2014-10-21       Impact factor: 6.902

Review 3.  Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology.

Authors:  David K Simon; Caroline M Tanner; Patrik Brundin
Journal:  Clin Geriatr Med       Date:  2019-08-24       Impact factor: 3.076

4.  Rotigotine Transdermal Patch: A Review in Parkinson's Disease.

Authors:  James E Frampton
Journal:  CNS Drugs       Date:  2019-07       Impact factor: 5.749

5.  Longitudinal risk factors for developing depressive symptoms in Parkinson's disease.

Authors:  Tarek Antar; Huw R Morris; Faraz Faghri; Hampton L Leonard; Mike A Nalls; Andrew B Singleton; Hirotaka Iwaki
Journal:  J Neurol Sci       Date:  2021-08-12       Impact factor: 4.553

6.  The Impact of Pallidal and Subthalamic Deep Brain Stimulation on Urologic Function in Parkinson's Disease.

Authors:  Stephen Mock; David J Osborn; Elizabeth T Brown; W Stuart Reynolds; Maxim Turchan; Srivatsan Pallavaram; William Rodriguez; Roger Dmochowski; Christopher M Tolleson
Journal:  Neuromodulation       Date:  2016-05-12

Review 7.  Copper and copper proteins in Parkinson's disease.

Authors:  Sergio Montes; Susana Rivera-Mancia; Araceli Diaz-Ruiz; Luis Tristan-Lopez; Camilo Rios
Journal:  Oxid Med Cell Longev       Date:  2014-01-08       Impact factor: 6.543

8.  Essential tremor: a neurodegenerative disease?

Authors:  Julián Benito-León
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2014-07-22

Review 9.  Isothiocyanates Are Promising Compounds against Oxidative Stress, Neuroinflammation and Cell Death that May Benefit Neurodegeneration in Parkinson's Disease.

Authors:  Giulia Sita; Patrizia Hrelia; Andrea Tarozzi; Fabiana Morroni
Journal:  Int J Mol Sci       Date:  2016-09-01       Impact factor: 5.923

10.  C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease.

Authors:  Alexandra Kleinknecht; Blagovesta Popova; Diana F Lázaro; Raquel Pinho; Oliver Valerius; Tiago F Outeiro; Gerhard H Braus
Journal:  PLoS Genet       Date:  2016-06-24       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.